John's Feed
Apr 5, 2011

Bankers see rebound in leveraged deals

TORONTO (Reuters) – Expect more debt-backed takeover bids like Valeant Pharmaceuticals’ (VRX.TO: Quote, Profile, Research, Stock Buzz) offer for Cephalon Inc (CEPH.O: Quote, Profile, Research, Stock Buzz) now that credit markets are largely recovered from the financial crisis, top bankers said on Tuesday.

Large leveraged deals, which were wildly popular just before the crisis, will gather steam both globally and in Canada given interest rates still at or near historic lows and increased investors confidence, bankers told the Toronto leg of the Reuters Global Mergers and Acquisitions Summit.

Mar 31, 2011

Valeant CEO showcases savvy dealmaking style

TORONTO (Reuters) – All it took was three years and 20 deals for Michael Pearson to aim at a $5.7 billion jackpot, and prove a formula devised in his days as a management consultant.

Pearson is leading the bid by Valeant Pharmaceuticals (VRX.TO: Quote, Profile, Research, Stock Buzz) (VRX.N: Quote, Profile, Research, Stock Buzz) to take over U.S. drugmaker Cephalon (CEPH.O: Quote, Profile, Research, Stock Buzz), his biggest bet so far on a theory that the traditional growth model — through heavy research and development spending — in the industry is broken.

Mar 30, 2011

Valeant CEO seeks speedy result on Cephalon bid

TORONTO/NEW YORK, March 30 (Reuters) – Valeant (VRX.TO: Quote, Profile, Research)
Pharmaceuticals (VRX.N: Quote, Profile, Research) may walk from from its $5.7 billion
offer for U.S. drugmaker Cephalon (CEPH.O: Quote, Profile, Research) within a month if it
can’t persuade shareholders to back the deal.

But Chief Executive Michael Pearson also said Valeant might
be willing to pay more for the cash-rich company, the
acquisition of which would expand Valeant’s lineup of drugs
into cancer treatments and other fields, if Cephalon can
persuade him it’s worth it.

Mar 30, 2011

Valeant to be disciplined in Cephalon bid-CEO

TORONTO, March 30 (Reuters) – Valeant Pharmaceuticals
International Inc (VRX.TO: Quote, Profile, Research, Stock Buzz) (VRX.N: Quote, Profile, Research, Stock Buzz) is not interested in a
bidding war for U.S. drugmaker Cephalon Inc (CEPH.O: Quote, Profile, Research, Stock Buzz), and Chief
Executive Michael Pearson said on Wednesday he was willing to
walk away.

But Pearson also said Valeant may consider raising its
offer if Cephalon opens up its books and the deal looks right.

Mar 29, 2011

Private equity hunts for the next Lululemon

TORONTO (Reuters) – Can Canada produce another retail sensation like Lululemon Athletica Inc (LLL.TO: Quote, Profile, Research, Stock Buzz), the yoga and sportswear maker that has grown nearly three-fold in as many years?

U.S. private equity firms flush with deployable cash are scouring Canada’s retail landscape to find out, said Ken Tuchman, vice-chairman of investment and corporate banking at BMO Capital Markets.

Mar 27, 2011

Canadian retailers seen as prime takeover targets

TORONTO, March 27 (Reuters) – Well-known Canadian clothiers
Le Chateau (CTUa.TO: Quote, Profile, Research, Stock Buzz), Jacob and Reitmans (RET.TO: Quote, Profile, Research, Stock Buzz) could become
takeover targets as a wave of U.S. retailers follows Target
Corp’s (TGT.N: Quote, Profile, Research, Stock Buzz) lead and seeks opportunities north of the
border.

There are plenty of reasons why Canadian retailers have
become so appealing: the country’s robust retail market, a
healthy economy, proximity to the huge U.S. market, a common
language and lower valuations of Canadian companies.

Mar 21, 2011

Yoga firm Lululemon: a downward facing stock?

TORONTO, March 21 (Reuters) – As the share price of
sportswear retailer Lululemon Athletica Inc (LLL.TO: Quote, Profile, Research, Stock Buzz) (LULU.O: Quote, Profile, Research, Stock Buzz)
heads toward the cost of its trendy $100 yoga pants, some
investors wonder if the market darling is heading for a fall.

The stock was at C$74.50 in Toronto on Monday, more than
double last August’s 52-week low of C$33.11, but still below
last month’s record high of C$84.36.

Mar 17, 2011

Lululemon sees soaring demand, pressure on inventory

TORONTO, March 17 (Reuters) – Lululemon Athletica Inc
(LLL.TO: Quote, Profile, Research, Stock Buzz) (LULU.O: Quote, Profile, Research, Stock Buzz) posted a higher quarterly profit on Thursday,
but said it was unable to meet the soaring demand for its yoga
and activewear gear in the current period.

U.S.-listed shares of the specialty clothier, which expects
cost pressures in 2011, initially dropped 6 percent in trading
before the opening bell, but later recovered somewhat.

Mar 11, 2011

Newly public Bauer eyes markets beyond ice hockey

TORONTO (Reuters) – Bauer Performance Sports Ltd (BAU.TO: Quote, Profile, Research, Stock Buzz), creator of the modern ice hockey skate, says it expects its initial public offering this week to herald growth in existing markets and expansion into new ones through acquisitions.

The 84-year-old Canadian company, now the world’s biggest maker of ice hockey gear, launched a C$75 million ($77 million) IPO on Thursday, floating a 30 percent stake.

Mar 6, 2011

Target entry won’t affect Canada retailers equally

TORONTO, March 6 (Reuters) – The imminent arrival of Target
Corp (TGT.N: Quote, Profile, Research, Stock Buzz) and other U.S. chain stores in the Canadian market
may drive smart investors to Canadian retailers that are most
insulated from the cross-border incursion.

Stores that compete most directly with Target, notably
clothiers and department stores, are not in an envious
position.